Response to immune checkpoint inhibition is associated with the gut microbiome in advanced KRAS-mutated non-small cell lung cancer
Hiddinga, B. I.; Bolte, L. A.; van der Leest, P.; Hijmering-Kappelle, L. B.; van der Wekken, A. J.; Schuuring, E.; Gacesa, R.; Hospers, G. A.; Weersma, R. K.; Bjork, J. R.; Hiltermann, T. J. N.
Show abstract
BackgroundKRAS-mutated non-small cell lung cancer (NSCLC) is associated with a poor prognosis to standard therapies. Despite advances of immune checkpoint inhibitors (ICIs), not all patients show durable responses. In this study, we aim to identify associations between ICI-response and the gut microbiome in patients with KRAS-mutated NSCLC. MethodsWe performed shotgun metagenomic sequencing of stool samples collected before ICI initiation from 33 patients with KRAS-mutated NSCLC. Microbiome composition within (-diversity) and between samples ({beta}-diversity) was calculated using Shannon diversity index and principal component analysis on Aitchison distances, respectively. A Bayesian logistic-normal regression model (Pibble) was implemented to identify associations between gut microbial features and disease control rate (DCR), progression free survival at 12 months (PFS12) and immune related adverse events (irAEs), adjusting for ICI-regimen, metastatic disease stage, age, sex and BMI. ResultsResponders were enriched with several saccharolytic species, including Agathobaculum butyriciproducens, Fusicatenibacter saccharivorans, Bifidobacterium longum and Eubacterium ramulus. Non-responders harbored higher abundances of several Bacteroides and Blautia species. Patients unaffected by irAEs demonstrated higher abundances of biotin and butyrate synthesis pathways. Development of irAEs was associated with higher Alistipes finegoldii, Bifidobacterium longum and Bacteroides uniformis abundance. No differences were observed between responders and non-responders in Shannon diversity index (P=0.69) and overall microbial composition (P=0.82). ConclusionsWe show gut microbial species and pathways that are differentially abundant between responders and non-responders to ICI in the setting of KRAS-mutated NSCLC. We find overlap with microbial signatures of response to ICI in other tumor types, potentially reflecting tumor-independent microbial mechanisms.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gut Microbiome Signatures Linked to HIV-1 Reservoir Size and Viremia Control 94%
- Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation 94%
- RapidAIM: A culture- and metaproteomics-based Rapid Assay of Individual Microbiome responses to drugs 94%
Similar papers in this journal
- Alterations of human lung and gut microbiome in non-small cell lung carcinomas and distant metastasis 95%
- HIV positive patients on antiretroviral therapy have an altered mucosal intestinal but not oral microbiome 93%
- Statistical evaluation of metaproteomics and 16s rRNA amplicon sequencing techniques for the study of the gut microbiota establishment of infants with cystic fibrosis 92%
Similar papers in this journal
Similar papers in this journal
- On the robustness of inference of association with the gut microbiota in stool, swab and mucosal tissue samples 95%
- Co-enrichment of cancer-associated bacterial taxa is correlated with immune cell infiltrates in esophageal tumor tissue 94%
- Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.